Biogen and Elan have reported two confirmed cases of a deadly brain infection - progressive multifocal leukoencephalopathy - in patients taking their Tysabri multiple sclerosis drug, according to a filing with the Securities and Exchange Commission.
Read article at pharmalot.com
Saturday 9 August 2008
Biogen's Tysabri has caused brain infection in two patients
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment